1h Free Analyst Time
The autoinjectors market is forecast to grow by $134014.58 mn during 2022-2027, accelerating at a CAGR of 25.14% during the forecast period.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergies and the need for immediate care, the growing popularity of injectable therapies, and the rise in commercial approvals of new products.
The autoinjectors market is segmented as below:
By Application
- Anaphylaxis
- Multiple sclerosis
- Rheumatoid arthritis
- Diabetes
By End-user
- Hospitals and clinics
- Self-administration
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The author presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on the autoinjectors market covers the following areas:
- Autoinjectors market sizing
- Autoinjectors market forecast
- Autoinjectors market industry analysis
Table of Contents
1 Executive Summary1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- Exhibit 13: Market segments
3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4.1 Global autoinjectors market 2017 - 2021
- Exhibit 18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
- Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
- Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
- Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
- Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
- Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- Exhibit 34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
- Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
- Exhibit 42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
- Exhibit 46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
- Exhibit 47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Market opportunity by Application ($ million)
- Exhibit 51: Data Table on Market opportunity by Application ($ million)
7.1 Market segments
- Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
- Exhibit 54: Chart on Comparison by End-user
- Exhibit 55: Data Table on Comparison by End-user
- Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
- Exhibit 61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
- Exhibit 64: Market opportunity by End-user ($ million)
- Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9.1 Geographic segmentation
- Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
- Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
- Exhibit 107: Market opportunity By Geographical Landscape ($ million)
- Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- Exhibit 111: Overview on factors of disruption
- Exhibit 112: Impact of key risks on business
12.1 Vendors covered
- Exhibit 113: Vendors covered
- Exhibit 114: Matrix on vendor position and classification
- Exhibit 115: AbbVie Inc. - Overview
- Exhibit 116: AbbVie Inc. - Product / Service
- Exhibit 117: AbbVie Inc. - Key news
- Exhibit 118: AbbVie Inc. - Key offerings
- Exhibit 119: Amgen Inc. - Overview
- Exhibit 120: Amgen Inc. - Product / Service
- Exhibit 121: Amgen Inc. - Key offerings
- Exhibit 122: Bayer AG - Overview
- Exhibit 123: Bayer AG - Business segments
- Exhibit 124: Bayer AG - Key news
- Exhibit 125: Bayer AG - Key offerings
- Exhibit 126: Bayer AG - Segment focus
- Exhibit 127: Becton Dickinson and Co. - Overview
- Exhibit 128: Becton Dickinson and Co. - Business segments
- Exhibit 129: Becton Dickinson and Co. - Key news
- Exhibit 130: Becton Dickinson and Co. - Key offerings
- Exhibit 131: Becton Dickinson and Co. - Segment focus
- Exhibit 132: Eli Lilly and Co. - Overview
- Exhibit 133: Eli Lilly and Co. - Product / Service
- Exhibit 134: Eli Lilly and Co. - Key offerings
- Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibit 140: GlaxoSmithKline Plc - Overview
- Exhibit 141: GlaxoSmithKline Plc - Business segments
- Exhibit 142: GlaxoSmithKline Plc - Key news
- Exhibit 143: GlaxoSmithKline Plc - Key offerings
- Exhibit 144: GlaxoSmithKline Plc - Segment focus
- Exhibit 145: Halozyme Therapeutics Inc. - Overview
- Exhibit 146: Halozyme Therapeutics Inc. - Product / Service
- Exhibit 147: Halozyme Therapeutics Inc. - Key offerings
- Exhibit 148: Merck KGaA - Overview
- Exhibit 149: Merck KGaA - Business segments
- Exhibit 150: Merck KGaA - Key news
- Exhibit 151: Merck KGaA - Key offerings
- Exhibit 152: Merck KGaA - Segment focus
- Exhibit 153: Owen Mumford Ltd. - Overview
- Exhibit 154: Owen Mumford Ltd. - Product / Service
- Exhibit 155: Owen Mumford Ltd. - Key offerings
- Exhibit 156: Pfizer Inc. - Overview
- Exhibit 157: Pfizer Inc. - Product / Service
- Exhibit 158: Pfizer Inc. - Key news
- Exhibit 159: Pfizer Inc. - Key offerings
- Exhibit 160: Recipharm AB - Overview
- Exhibit 161: Recipharm AB - Business segments
- Exhibit 162: Recipharm AB - Key offerings
- Exhibit 163: Recipharm AB - Segment focus
- Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
- Exhibit 169: Viatris Inc. - Overview
- Exhibit 170: Viatris Inc. - Business segments
- Exhibit 171: Viatris Inc. - Key offerings
- Exhibit 172: Viatris Inc. - Segment focus
- Exhibit 173: Ypsomed AG - Overview
- Exhibit 174: Ypsomed AG - Business segments
- Exhibit 175: Ypsomed AG - Key offerings
- Exhibit 176: Ypsomed AG - Segment focus
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist
- Exhibit 179: Currency conversion rates for US$
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources
- Exhibit 183: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Becton Dickinson and Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Halozyme Therapeutics Inc.
- Johnson and Johnson Services Inc.
- Johnson Medtech LLC
- medmix Ltd.
- Merck KGaA
- Owen Mumford Ltd.
- Pfizer Inc.
- RAVIMED Sp. zoo
- Recipharm AB
- SHL Medical AG
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Ypsomed AG
